Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Johnson & Johnson
(NY:
JNJ
)
158.97
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Aug 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Johnson & Johnson
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Teva Pharma is the way to play the re-rise of generic drugs
November 28, 2023
Generic and specialty pharmaceutical company, Teva Pharmaceutical's stock, has underperformed for years, but a potential spinoff may be a catalyst for growth
Via
MarketBeat
Heart Failure Drugs Market Critical Analysis with Expert Opinion : Johnson & Johnson, Pfizer, Roche
November 24, 2023
Global Heart Failure Drugs Market Breakdown by Application (Reduced Ejection Fraction, Preserved Ejection Fraction) by Type (ACE inhibitors, Beta Blockers, Diuretics, Sacubitril Valsartan, Others) by...
Via
SBWire
Skin Tightening Products Market to Witness Massive Growth by 2029 : L'Oréal, Johnson & Johnson, Amway
November 22, 2023
Stay up to date with Skin Tightening Products Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
Memory Implants Market Set for More Growth : NextMind, Johnson & Johnson, Neuralink
November 16, 2023
Get Memory Implants Market analysis, key vendors & competitive scenario of the market prepared using market research tools such as Porter’s five forces and SWOT analysis.
Via
SBWire
South Carolina Life Sciences Conference Expects Record Attendance, 30 National Speakers
November 14, 2023
GREENVILLE, S.C. - Nov. 14, 2023 - PRLog -- The largest life sciences conference in Palmetto State history will convene February 6-8 in Greenville, and national site selection consultants and media...
Via
PRLog
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Economy
Johnson & Johnson to Host Enterprise Business Review
November 16, 2023
From
Johnson & Johnson
Via
Business Wire
Buffett's latest portfolio additions, trims and cuts in Q3
November 16, 2023
Buffett's Berkshire latest Q3 moves: Acquires Sirius XM, Atlanta Braves; trims HP, Chevron, Amazon; holds onto Apple, Bank of America.
Via
MarketBeat
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Wall Street sees these 2023 losers as 2024 opportunities
November 09, 2023
Analysts are pointing at undervalued, oversold companies like these three S&P 500 laggards as potential investment opportunities heading into 2024.
Via
MarketBeat
Topics
Stocks
Exposures
US Equities
MarketBeat Week in Review – 10/30 - 11/3
November 04, 2023
Equities rallied as the theme of bad news is good news is back; investors now wait for the latest read on inflation and its impact on holiday spending
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Get Ready for Next Generation of Diabetes, Weight-Management Drugs
November 01, 2023
Via
Investor Brand Network
Get Ready for Next Generation of Diabetes, Weight-Management Drugs
November 01, 2023
EQNX::TICKER_START (NASDAQ:LEXX),(NYSE:JNJ),(NYSE:SNY),(NASDAQ:AMGN),(NYSE:NVS) EQNX::TICKER_END
Via
FinancialNewsMedia
Investor patience tested as pharmaceutical stocks take a tumble
November 01, 2023
The healthcare sector faces a selloff as pharmaceutical giants report lackluster earnings; even Amgen's strong results failed to prevent selling in the sector
Via
MarketBeat
J&J stock down as business unit mulls talc-related bankruptcy
October 31, 2023
Johnson & Johnson stock fell in the past week as talc-related lawsuits weigh on a subsidiary, which is mulling bankruptcy to mitigate payouts and settlements.
Via
MarketBeat
Topics
Bankruptcy
Lawsuit
Exposures
Financial
Legal
Are These 3 Dividend Aristocrats Undervalued Hidden Gems?
October 25, 2023
Dividend aristocrats Caterpillar, NextEra, and Clorox have shown resilience in challenging times. These may offer opportunities as they are trading off highs.
Via
MarketBeat
Exposures
COVID-19
Johnson & Johnson Announces Departure of Ashley McEvoy, Tim Schmid Named Executive Vice President, Worldwide Chairman of MedTech
October 23, 2023
From
Johnson & Johnson
Via
Business Wire
The Value Deepens for Medtech Stocks: Reversal Imminent
October 23, 2023
MedTech stocks are performing well and supported by pent-up demand, yet share prices are trading at significant and often historical lows.
Via
MarketBeat
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2023
October 19, 2023
From
Johnson & Johnson
Via
Business Wire
Oversold and Overextended, Abbott Laboratories is a Great Buy
October 18, 2023
Abbott Laboratories rises on solid results and guidance; the value and dividend are at the best levels in years, and the sell-side is buying.
Via
MarketBeat
Exposures
COVID-19
Johnson & Johnson Reports Q3 2023 Results
October 17, 2023
From
Johnson & Johnson
Via
Business Wire
Steroids Market Is Set to Fly High in Years to Come : Pfizer, Johnson & Johnson, Bayer
October 10, 2023
Stay up to date with Steroids Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
3 Undervalued Healthcare Stocks to Watch as Sector Struggles
October 06, 2023
As the healthcare sector slumps, several major stocks, including Zimmer Biomet, Moderna, and Illumina, appear undervalued in contrast to their intrinsic worth.
Via
MarketBeat
3 Blue Chip Safe Havens to Shield Your Portfolio
September 25, 2023
As the market experiences heightened volatility and uncertainty, it's worth exploring defensive stocks like JNJ, PG, and VZ for stability amid the uncertainty.
Via
MarketBeat
Topics
ETFs
Economy
Exposures
Economy
Interest Rates
3 Reasons SharkNinja Is Swimming Toward New Highs
September 22, 2023
Shares of SharkNinja, Inc. are up more than 50% since August 4th — and becoming a popular momentum bet amongst retail traders.
Via
MarketBeat
Flee to Healthcare Stocks if Recession Rears its Head?
September 20, 2023
In uncertain economic conditions, healthcare stocks can be a refuge due to steady demand and favorable inflation conditions. Many also offer dividends.
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
The Breakthrough Therapy Aiming To Solve The World’s Mental Health Crisis
September 19, 2023
EQNX::TICKER_START (NYSE:JNJ),(NYSE:ABBV),(NASDAQ:ATAI),(NASDAQ:CMPS),(NASDAQ:MNMD) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Economy
Exposures
Economy
Product Safety
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
September 18, 2023
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson Marks New Era as Global Healthcare Company With Updated Visual Identity
September 14, 2023
From
Johnson & Johnson
Via
Business Wire
Dividend Growth Rates and How to Calculate Them
September 08, 2023
Via
MarketBeat
7 Best Blue Chip Stocks to Buy Now
September 08, 2023
Blue-chip stocks are the stocks of well-known, high-quality industry leaders. Learn more about our top picks for the best blue chip stocks to buy now.
Via
MarketBeat
Global Dry Eye Syndrome Treatment Market Expected to Reach $11.26 Billion By 2030
September 08, 2023
EQNX::TICKER_START (NASDAQ:OKYO),(NYSE:ALC),(NYSE:BLCO),(NYSE:JNJ),(OTCQX:RHHBY) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
COVID-19
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.